Virtual Tumor Board Events

MSK physicians collaborate with hospitals and physicians from around the world on virtual tumor board events to deepen our understanding of cancer and to discuss effective and innovative approaches for treatments.

Tumor board moderated by Dr. Andrew Seidman and Dr. Jasmeet Singh.
VIDEO | 02:54:29
Two of today’s most challenging aspects of oncology are interpreting results from next-generation genomic sequencing and identifying the right drug for the right patient. Join global oncology experts from MSK and M | O | C Cancer Care & Research for an insightful discussion on how molecular profiling is transforming breast cancer treatment.
Tumor board moderated by Dr. Andrew Seidman and Dr. Jasmeet Singh.
VIDEO | 02:16:51
Interpreting diagnostic results and developing optimal treatment plans for invasive lobular breast cancer can be challenging. Join global oncology experts from MSK and Bharatiya Medical College for an insightful presentation on the complexities of diagnosing and treating this unique subtype of breast cancer.
Tumor board moderated by Dr. Andrew Seidman and Dr. Jasmeet Singh.
VIDEO | 01:59:39
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) facilitates a discussion with experts from MSK and Max Healthcare (India) about the unique clinical scenarios, challenges, and global perspectives associated with metaplastic breast cancer.
Tumor board moderated by Dr. Dennis Chi, MSK and Dr. Rema P, RCC, Thiruvananthapuram
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. Doctors from MSK in New York partnered with doctors from RCC, Thiruvananthapuram to present two mucinous ovarian neoplasms cases as part of an ongoing multidisciplinary tumor board series.
Tumor board moderated by Dr. Jasmeet C. Singh, MSK, New York and Dr. Andrew D. Seidman, MSK, New York of MSK and Dr. Atul Batra of AIIMS, India.
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) and Dr. Atul Batra (AIIMS, India) moderate a discussion with their fellow world-renowned colleagues about the management of oligoprogression in breast cancer.
Tumor board moderated by Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai and Dr. Mrinal Gounder of Memorial Sloan Kettering Cancer Center (MSK)
Join leading global experts to discover best practices on interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient.
Tumor board directed by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital, Mumbai.
The second in an ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai, this tumor board focused on the BRAF pathway.
Tumor board moderators Dr. Jennifer Mueller of MSK and Dr. Thomas Samuel Ram of CMC Vellore
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To share expertise, advance research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this particular event, we are honored to partner with CMC Vellore in India.
Tumor board moderated by Dr. Snehal Patel of MSK and Dr. Anil D'Cruz of Apollo Hospital in Delhi.
Partnering with Apollo Hospital in Mumbai, India the multidisciplinary tumor board on May 19 included presentations on margin assessment, along with case studies on management of early oral cancer as well as locally advanced oral cancer.
Tumor board directed by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital, Mumbai.
VIDEO | 1:57:00
The first in an ongoing series, this tumor board focused on the emerging and important KRAS pathway.
Tumor board moderated by Dr. Jennifer Mueller from MSK and Dr. Nitesh Rohatgi from Fortis Healthcare.
VIDEO | 1:29:16
Partnering with Fortis Healthcare in Gurugram, India, this Multidisciplinary Tumor Board on March 31, 2023 explored cases and lectures on endometrial stromal sarcoma (ESS) and uterine leiomyosarcoma (LMS).
Dr. Moni A. Kuriakose, Head and Neck Surgeon MSCC Bangalore and Dr. Bhuvanesh Singh, Head and Neck Surgeon MSK.
VIDEO | 1:36:28
Partnering with Mazumdar Shaw Cancer Center (MSCC) in Bangalore, this Multidisciplinary Tumor Board on January 21, 2023 explored the diagnosis and management of potentially malignant lesions in the oral cavity. The tumor board was moderated by head and neck surgeons Dr. Bhuvanesh Singh from MSK and Dr. Moni A. Kuriakose from MSCC.
Dr. Mario M. Leitao, GYN Surgeon MSK, and Dr. Sachin Khurana, Medical Oncologist, AIIMS, New Delhi.
VIDEO | 1:29:38
Partnering with AIIMS in New Delhi, the Multidisciplinary Tumor Board on Cervical Cancer explored two complex cases involving recurrent endocervical adenocarcinoma and relapsed cervical carcinoma. It also featured presentations on systemic therapies and novel targets and prevention of cervical cancer in India.
MSK Surgeon Dr. Ashok Shaha and Dr. Arvind Krishnamurthy, Surgeon From the Cancer Institute (WIA)
VIDEO | 2:02:44
In our joint tumor board on complex thyroid cancer, we explored three patient cases involving anaplastic, medullary, and recurrent differentiated thyroid cancer. Following these cases was a presentation and discussion about tracheal resections in thyroid cancer.
Moderators Dr. Kara Long Roche & Dr. Jayasharee Natarajan
VIDEO | 1:40:00
We were honored to co-host the event with the Cancer Institute (WIA), Adyar, Chennai. In this joint tumor board, we discussed two patients with serious ovarian cancer in the early and late stage. We also heard from the expert panelists on current management as well as the latest advances and ongoing research in this field.
Moderators Dr. Jatin Shah and Dr. Krishnakumar Thankappan
VIDEO | 2:04:22
The host institution for this head and neck event on skull base malignancies was Amrita Hospital in Kochi. Two cases were discussed including: ethmoid cancer suitable for endonasal resection and locally advanced malignant tumor involving the skull base/orbit. This was followed by two lectures: Principles of Reconstructive Surgery Following Major Skull Base Resection With or Without Orbital Exenteration and 2022 Outcomes of International Collaborative Study on Skull Base Surgery.
Moderator Dr. Jatin Shah of MSK
VIDEO | 1:41:48
This head and neck event, a joint tumor board on salivary cancer, was moderated by Dr. Richard Wong of MSK and Dr. Kaustubh Patel of HCG. Two cases involving parotid cancer were discussed, followed by lectures on parotid surgery and nuances in facial construction, and nuances in facial reanimation.
tbd
VIDEO | 45:26
During our event focused on ovarian cancer, we had the distinct privilege to present a conversation between Ms. Manisha Koirala and Dr. William Breitbart about the patient perspective.
Presentation cover of ovarian cancer tumor board
VIDEO | 36:57
We were excited to present an educational series between MSK and the Association of Gynaecologic Oncologists of India (AGOI). We were honored to co-host with Tata Medical Center in Kolkata and discussed treatment management of two serious ovarian cancer cases: platinum-sensitive recurrent ovarian cancer and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.